Healthlynked Stock Price, News & Analysis

HealthLynked (OTCQB: HLYK) appointed Duncan McGillivray as Chief Operating Officer effective Dec 8, 2025 to drive operational scale-up, national expansion and a planned Nasdaq uplisting in 2026. McGillivray brings 30+ years of healthcare, technology and finance experience, including advising on more than $1 billion in healthcare projects, work linked to the U.S. Treasury's $76 billion New Markets Tax Credit allocation, and support for over $200 million in funded healthcare projects. He will lead capital formation, banking relations, payer and employer partnership support, and rollout of ARI, HealthLynked's patented AI healthcare guide, while engaging on TEFCA, "Kill the Clipboard," and the Genesis Mission.

HealthLynked (OTCQB:HLYK) appointed two insurance executives to its board on Dec 2, 2025: Chris G. Pulos of Marsh McLennan and Jason Bishara of NSI Insurance. The hires add expertise in employer benefits, value‑based care, risk alignment, and fintech as HealthLynked scales partnerships with payers, employer groups, and ACOs.

The company highlighted deployment of its patented AI guide ARI (developed with OpenAI), national interoperability initiatives, a target of serving more than one million users, and plans to complete a Nasdaq Capital Markets listing.

HealthLynked (OTCQB: HLYK) has retained NE Holdings, LLC under a Capital Market Advisory Agreement to support its planned Nasdaq Capital Market listing targeted for the first half of 2026. NE Holdings will provide corporate readiness, financial structuring, audit coordination, investment banking introductions, and governance development. The company also engaged an investment bank to underwrite an offering and has filed its Nasdaq application as part of a broader public-market expansion strategy.

HealthLynked (OTCQB: HLYK) launched a new MedOfficeDirect e-commerce platform on Shopify at DiscountOnlineMedicalSupplies.com on October 24, 2025. The site offers a curated inventory with an average of 20% lower prices across brand-name medical supplies, faster performance, enhanced security, and a modern checkout powered by Shopify and Shop Pay.

The company plans to expand SKUs, migrate marketing, SEO, and backend systems to Shopify, then return the platform to its primary domain MedOfficeDirect.com and integrate it with HealthLynked's patient network and rewards program.

HealthLynked (OTCQB: HLYK) has filed two significant patent applications to enhance its healthcare technology portfolio. The first patent covers a Universal Patient Identifier (UPIN) system that creates unique medical record identifiers without using Social Security numbers, improving security and record connectivity across EMR platforms.

The second patent involves an AI Appointment Scheduling Agent, a multilingual system that intelligently books medical appointments while considering patient history, preferences, and insurance networks. These innovations build upon HealthLynked's early adoption of AI in healthcare, particularly in care management using large language models.

HealthLynked (OTCQB: HLYK) has completed a strategic reverse stock split to strengthen its market position and capital structure. The company aims to improve visibility and access to institutional investors while maintaining shareholders' percentage ownership. This move is part of HealthLynked's broader strategy to support potential uplisting opportunities.

The company has recently launched ARi, its patented AI healthcare guide, and is expanding its nationwide telemedicine platform. HealthLynked is in discussions with major insurance carriers for integrating its technology into care management workflows, which could generate substantial recurring revenue. The company is also expanding its intellectual property portfolio in healthcare and AI technologies.

HealthLynked (OTCQB: HLYK) has announced a nationwide initiative to accelerate medical research by connecting patients with pharmaceutical and biotech partners through its technology platform. The company, with over 1 million registered members, will roll out research collaboration programs between Q3 2025 and January 2026.

The initiative includes five key partnership tracks: cohort finder & feasibility, recruitment & eConsent, ePROs & RWE generation, signal & safety monitoring, and natural history & rare disease registries. The platform is supported by ARi, an AI healthcare agent built with OpenAI technologies, to analyze patient data and identify trends. Patients can join for free or access premium features for $12/month.

HealthLynked (OTCQB: HLYK) has announced two major platform enhancements: a new Enterprise Healthcare Solutions Website (www.hlykgroup.com) and an upgraded provider directory. The enterprise platform targets key healthcare stakeholders including insurance carriers, pharmaceutical companies, ACOs, and large employers, offering solutions for patient engagement, population health, and cost management.

The company has also implemented significant improvements to its provider directory, featuring faster performance and localized provider suggestions. These updates aim to enhance user experience and provide patients with more targeted healthcare options.

Led by CEO Dr. Michael Dent, these developments position HealthLynked as a comprehensive healthcare technology partner focused on improving healthcare access and coordination while delivering enterprise-scale efficiency.

HealthLynked (OTCQB: HLYK) has engaged Meridian Group as a strategic advisory firm to accelerate growth and explore potential uplisting to Nasdaq. The partnership aims to identify strategic alliances with healthcare insurers, administrators, systems, and technology providers to expand HealthLynked's healthcare ecosystem, which includes telemedicine, patient record management, and AI-driven care solutions.

David Chua, Director at Meridian Group, joins as strategic advisor to help establish banking relationships and drive platform adoption through enterprise deployment, channel expansion, and vertical integration. The engagement focuses on accelerating revenue growth, enhancing shareholder value, and evaluating synergistic acquisition opportunities.